Dr. Hsu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
# Seattle
Seattle, WA 98105Phone+1 206-987-2000
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Gastroenterology, 2007 - 2011
- University of WashingtonResidency, Pediatrics, 2003 - 2006
- University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
- HI State Medical License 2023 - 2026
- MT State Medical License 2022 - 2026
- WA State Medical License 2003 - 2026
- ID State Medical License 2022 - 2025
- OR State Medical License 2020 - 2025
- AK State Medical License 2021 - 2024
- PA State Medical License 2007 - 2012
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Clinical Trials
- TReatment for ImmUne Mediated PathopHysiology Start of enrollment: 2022 Feb 09
Roles: Contact, Principal Investigator
- Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai Start of enrollment: 2021 Jul 08
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 21 citationsPrevalence and Outcomes of Liver Transplantation in Children With Intellectual Disability.Aaron Wightman, Evelyn K. Hsu, Qianqian Zhao, Jodi M. Smith
Journal of Pediatric Gastroenterology and Nutrition. 2016-06-01 - 10 citationsPrevalence and Long-Term Outcomes of Solid Organ Transplant in Children with Intellectual Disability.Aaron Wightman, Miranda C. Bradford, Evelyn K. Hsu, Heather L. Bartlett, Jodi M. Smith
The Journal of Pediatrics. 2021-03-29 - 90 citationsIn Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.Jeffrey B. Schwimmer, Joel E. Lavine, Laura Wilson, Brent A. Neuschwander-Tetri, Stavra A. Xanthakos
Gastroenterology. 2016-12-01
Journal Articles
- Pediatric End-Stage Liver Disease Scores as a Method of Assessing Mortality Risk or Prioritization to TransplantabilityEvelyn K Hsu, Simon P Horslen, Jorge D Reyes, JAMA
Press Mentions
- “We’re Not Just Transplanting Organs, We’re Transplanting Lives”April 25th, 2022
- #NASPGHAN19 Liver Symposium (Part 3)October 21st, 2019
- Children Lose Out on Liver Transplants, Study FindsSeptember 17th, 2018
- Join now to see all
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: